Literature DB >> 15258199

Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.

Junichi Shoda1, Yoichi Inada, Atsutoshi Tsuji, Hiroshi Kusama, Tetsuya Ueda, Tadashi Ikegami, Hiroshi Suzuki, Yuichi Sugiyama, David E Cohen, Naomi Tanaka.   

Abstract

Fibrates, including bezafibrate (BF), upregulate the expression of ATP binding cassette protein B4 (ABCB4) through gene transcription in mice. To determine the effects of BF on the expression levels of ABCB4 and on the stimulation of biliary phosphatidylcholine (PC) transport in human HepG2 hepatoblastoma cells, mRNA and protein levels as well as subcellular localization were investigated in the cells treated with BF. The canalicular accumulation of a fluorescent PC was assessed by confocal laser scanning microscopy. Treatment with 300 micromol/l BF for 24 h increased levels of ABCB4 mRNA but not protein by up to 151%. BF caused redistribution of ABCB4 into pseudocanaliculi formed between cells. In association with this redistribution, BF accelerated the accumulation of fluorescent PC in bile canaliculi (up to 163% of that in nontreated cells). Suppression of peroxisome proliferator-activated receptor alpha (PPARalpha) expression by either a small interfering RNA duplex or morpholino antisense oligonucleotide attenuated the BF-induced redistribution of ABCB4. These findings suggest that BF may enhance the capacity of human hepatocytes to direct PC into bile canaliculi via PPARalpha-mediated redistribution of ABCB4 to the canalicular membrane. This provides a rationale for the use of BF to improve cholestasis and/or cholangitis that is attributable to hypofunction of ABCB4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258199     DOI: 10.1194/jlr.M400132-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  21 in total

Review 1.  Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

Authors:  Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Pflugers Arch       Date:  2006-04-19       Impact factor: 3.657

2.  Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion.

Authors:  Nisanne S Ghonem; Meenakshisundaram Ananthanarayanan; Carol J Soroka; James L Boyer
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

3.  Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.

Authors:  Denis A Mogilenko; Igor V Kudriavtsev; Vladimir S Shavva; Ella B Dizhe; Ekaterina G Vilenskaya; Alexander M Efremov; Andrej P Perevozchikov; Sergey V Orlov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

4.  The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression.

Authors:  Munechika Enjoji; Ryoko Yada; Tatsuya Fujino; Tsuyoshi Yoshimoto; Masayoshi Yada; Naohiko Harada; Nobito Higuchi; Masaki Kato; Motoyuki Kohjima; Akinobu Taketomi; Yoshihiko Maehara; Manabu Nakashima; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  Hepatol Int       Date:  2009-06-16       Impact factor: 6.047

5.  Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs.

Authors:  Vladimir S Shavva; Denis A Mogilenko; Ekaterina V Nekrasova; Andrey S Trulioff; Igor V Kudriavtsev; Ekaterina E Larionova; Anna V Babina; Ella B Dizhe; Boris V Missyul; Sergey V Orlov
Journal:  Mol Cell Biochem       Date:  2018-02-13       Impact factor: 3.396

Review 6.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

7.  Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model.

Authors:  Ali Jalilian; Taghi Golmohammadi; Reza Meshkani; Mehdi Koushki; Neda Eivazi; Reyhaneh Babaei Khorzoughi; Seyed Reza Hosseini Fard; Maliheh Paknejad
Journal:  Mol Biol Rep       Date:  2021-02-12       Impact factor: 2.316

8.  A human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humans.

Authors:  Katsutoshi Yoshizato; Chise Tateno
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

Review 9.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

10.  The Multiple Facets of ABCB4 (MDR3) Deficiency.

Authors:  Shikha S Sundaram; Ronald J Sokol
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.